Wegovy and the inner thigh: separating fact from popular assumption

The myth: the inner thigh works just as well as anywhere else

It's an easy assumption to make. The thigh is a standard injection site for many medicines, and the inner thigh can seem convenient. The problem is that "the thigh" in clinical guidance specifically means the front or outer area — the anterolateral surface, in the language of the Patient Information Leaflet. The inner thigh is softer, more vascular, and considerably thinner in subcutaneous tissue than the outer portion. That matters because Wegovy is designed to be absorbed slowly through the fat layer just beneath the skin. If the needle reaches muscle instead, absorption changes unpredictably and bruising is more likely.

If you're currently injecting into the inner thigh because it felt more accessible, you're not alone, it's a question our prescribers hear. The right move is to mention it at your next clinical review rather than continuing quietly.

For a broader look at thigh injections in general, our page on using the thigh as a Wegovy injection site explains technique for the approved area.

What the approved sites actually give you, and how to choose between them

The three licensed sites (outer thigh, abdomen, upper arm) were selected in clinical trials because they offer reliably consistent subcutaneous tissue depth across most adult body types. Each has practical trade-offs.

The abdomen (at least 5 cm from the navel) is the most commonly used site because it's easy to reach without assistance and tends to have adequate tissue depth. Many people find the outer thigh straightforward when sitting down, though it does require careful placement to stay on the outer surface rather than drifting inward. The upper arm is convenient if someone else is administering your injection, but awkward to self-inject accurately, most people rely on a mirror or a helper.

Comparing how the thigh and stomach actually compare for comfort and absorption is something a lot of patients ask about. Our page on Wegovy: stomach or thigh covers the practical detail.

Rotate the site each week. Repeated injections into the same small area can cause lipohypertrophy, a localised hardening of fatty tissue that slows absorption. That means less predictable weight-loss progress, not just a cosmetic issue.

Injection-site reactions: what's normal, what isn't

Some redness, mild bruising, or temporary itching at the injection site is common, particularly in the first few weeks of treatment or after a dose increase. These reactions are generally mild and settle within a day or two. Reporting persistent or severe reactions through the MHRA Yellow Card scheme helps regulators track real-world safety data and is something any patient can do directly.

Signs worth flagging to your prescriber promptly include a lump that persists beyond a week, skin that is consistently warm or discoloured at the site, or any sign of infection. Wegovy's side-effect profile is predominantly gastrointestinal (nausea, loose stools, reduced appetite) rather than site-related, but injection-site problems do occur and shouldn't be dismissed. If you're unsure whether what you're experiencing is typical, our clinical support team is available seven days a week.

For a more detailed look at how semaglutide works and what the clinical evidence shows, our semaglutide overview is a good starting point.

Getting your injection technique right from the start

Good technique reduces both side effects and anxiety about injecting. A few practical points grounded in clinical guidance:

Use a fresh needle for each injection. Clean the skin with an alcohol swab and let it dry before you inject, injecting through wet skin stings. Pinch a fold of skin gently if you have limited subcutaneous tissue; release the pinch before withdrawing the pen. After injecting, apply light pressure with a dry cotton pad rather than rubbing, which can cause unnecessary bruising. Never inject into skin that is broken, bruised, scarred, or has active lipohypertrophy.

If you're considering switching injection site between doses, our page on the Wegovy thigh injection covers placement in practical terms. And if a question has come up about whether semaglutide affects anything beyond weight and appetite, the page on whether Wegovy is a blood thinner addresses one of the more common misconceptions we see.

Wegovy is a prescription medicine. If you're not yet in treatment and want to understand whether it could be appropriate for your circumstances, speaking to our prescribers through a free consultation is where that conversation starts. Our Wegovy treatment page gives a fuller picture of how we support patients through each stage.